Shock wave treatment of salivary duct stones: substantial progress with a minilithotripter.
Extracorporeal shock wave lithotripsy has recently been introduced as the first non-operative treatment alternative for patients with sialolithiasis. Using conventional multipurpose lithotripters, however, successful treatment was achieved in only 36%-53% of patients. Therefore we developed an miniaturized lithotripter meeting the special requirements for extracorporeal shock wave treatment in the head and neck region. During a 1-year prospective trial clinical efficacy and safety were compared in 40 patients treated with a conventional electromagnetic lithotripter (group A) to 33 patients treated with the newly developed, miniaturized device (group B). The groups did not differ statistically regarding stone size or number or the proportion of stones located in the submandibular or parotid gland. Successful stone targeting, a prerequisite for shock wave treatment, was achieved by means of in-line ultrasonography in 30 of the 40 patients in group A and in 29 of 33 patients of group B. The number of shock wave impulses administered per session and the maximum shock wave intensities did not differ in the two groups. Significantly more frequent treatments with a longer mean duration of each session were required in group A (2.4 +/- 1.0 treatments, 47 +/- 11 min) than in group B (1.9 +/- 0.7 treatments, 28 +/- 9 min; P < 0.05). After a 3 month follow-up significantly more patients were free of stones in group B (22/33) than in group A (16/40; P < 0.05). Correspondingly, the number of patients free of complaints was significantly higher in group B (27/33) than in group A (22/40; P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
Wehrmann
T
T
Medizinische Klinik II, Universitätsklinikum, Frankfurt/Main, Germany.
Kater
W
W
Marlinghaus
E H
EH
Peters
J
J
Caspary
W F
WF
D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008096:Lithotripsy / Q000009:adverse effects / Q000295:instrumentation; D008297:Male; D011446:Prospective Studies; D012465:Salivary Duct Calculi / Q000628:therapy*; D016896:Treatment Outcome